ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Paris-based Biolevate raised €30m in Series A funding co-led by Orange Ventures and RAISE France to expand its AI automation platform for regulated life sciences. The company opened a Boston office, serves over 12 enterprise customers, and claims 20-fold annual recurring revenue growth. It plans to double its 50-person team next year.
Tap to vote and see what everyone thinks.
Summary by ByteBrief